Lindus Health Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 132

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $55M

  • Investors
  • 27

Lindus Health General Information

Description

Operator of an anti-contract research organization intended to deliver end-to-end clinical trials for health and biotech companies. The company's software allows access to electronic health records, design, patient recruitment, clinical data capture, monitoring, and project management, while reducing the risk of clinical trial failure, enabling health experts to accelerate clinician trials and improve patient treatment outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, 90 Union Street
  • London SE1 0NW
  • England, United Kingdom
Primary Industry
Other Healthcare Technology Systems
Other Industries
Drug Discovery
Corporate Office
  • 2nd Floor, 90 Union Street
  • London SE1 0NW
  • England, United Kingdom

Lindus Health Timeline

2022202320242025
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lindus Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 22-Jan-2025 $55M Completed Generating Revenue
4. Accelerator/Incubator 10-Sep-2024 Completed Generating Revenue
3. Early Stage VC (Series A) 09-Aug-2023 Completed Generating Revenue
2. Grant 17-May-2023 $625K $8.48M Completed Generating Revenue
1. Early Stage VC (Series 3) 08-Nov-2021 $8.48M $8.48M Completed Generating Revenue
To view Lindus Health’s complete valuation and funding history, request access »

Lindus Health Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 Preferred
Series A-1 Preferred
Preference 659,361 $0.000001 $6.24 $6.24 1x $6.24 16.45%
Preference 43,237 $0.000001 $5.3 $5.3 1x $5.3 1.08%
To view Lindus Health’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lindus Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of an anti-contract research organization intended to deliver end-to-end clinical trials for health and biotech
Other Healthcare Technology Systems
London, United Kingdom
132 As of 2025

New York, NY
 

Atlanta, GA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lindus Health Competitors (6)

One of Lindus Health’s 6 competitors is Koneksa, a Venture Capital-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Koneksa Venture Capital-Backed New York, NY
Florence (Healthcare Technology Systems) Venture Capital-Backed Atlanta, GA
Science 37 Holdings Formerly VC-backed Morrisville, NC
Curebase Venture Capital-Backed San Francisco, CA
Vial (Biotechnology) Venture Capital-Backed San Francisco, CA
To view Lindus Health’s complete competitors history, request access »

Lindus Health Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lindus Health Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds
Balderton Capital Venture Capital Minority
Visionaries Club Venture Capital Minority
Tech Nation Group Accelerator/Incubator
271.vc Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 27 investors. Get the full list »

Lindus Health FAQs

  • When was Lindus Health founded?

    Lindus Health was founded in 2021.

  • Where is Lindus Health headquartered?

    Lindus Health is headquartered in London, United Kingdom.

  • What is the size of Lindus Health?

    Lindus Health has 132 total employees.

  • What industry is Lindus Health in?

    Lindus Health’s primary industry is Other Healthcare Technology Systems.

  • Is Lindus Health a private or public company?

    Lindus Health is a Private company.

  • What is Lindus Health’s current revenue?

    The current revenue for Lindus Health is .

  • How much funding has Lindus Health raised over time?

    Lindus Health has raised $81.1M.

  • Who are Lindus Health’s investors?

    Balderton Capital, Visionaries Club, Tech Nation Group, 271.vc, and are 5 of 27 investors who have invested in Lindus Health.

  • Who are Lindus Health’s competitors?

    Koneksa, Florence (Healthcare Technology Systems), Science 37 Holdings, Curebase, and Vial (Biotechnology) are some of the 6 competitors of Lindus Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »